Browsing by Author Horvath, N

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2015Management of Systemic AL Amyloidosis: Recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupHo, Joy Phoebe; Augustson, B; Brown, R; Catley, Laurence; Douglas, Joshua; et al, Various; Gibson, J; Harrison, S; Horvath, N; Jaksic, W; Mollee, P.; Quach, H; Weber, N; Central Clinical School: MedicineManagement of Systemic AL Amyloidosis: Recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group, Internal Medicine Journal, vol.45, 4, 2015,pp 371-382
2005Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation.Gibson, John; Prosser, Ian; Bashford, J; et, al; Grigg, Andrew P.; Herrmann, R; Horvath, N; Joske, D; Lowenthal, R; McKendrick, J; Prince, Roger C; Spencer, Andrew; Central Clinical School: Medicine; MedicineProspective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation., Bone Marrow Transplantation, vol.35,(10),2005,pp 971-7
2012Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1Allen, John; Al-Shabeeb, Ammira; Ho, Phoebe (Joy); Iland, Harry; Joshua, Douglas; Lau, Edwin; Ling, Silvia; Nikolic, Angela; Catalano, Alberto; Fleming, Shaun; Harrison, Simon James; Horvath, N; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Centenary Institute; Central Clinical School: Centenary Institute; Melanoma FoundationResponse of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1, Haematologica: the hematology journal, vol.97, 1, 2012,pp 64-72